Medication info
Linagliptin Tablets (Linagliptin)

Linagliptin Tablets (Linagliptin)

Prescription medicationTablet
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablet in pink color
Packaging
28 tablets (14 tablets/PTP x 2), 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201900194 · Approved 2019.01.16 · Insurance code 642906790

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5 mg once daily. It may be administered without regard to meals. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood glucose levels. It plays a supportive role alongside dietary and exercise regimens and can be administered alone or in combination with other medications. This enables effective management of blood glucose levels and aids in diabetes treatment.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5 mg once daily. It may be administered without regard to meals. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used by patients who have allergies to the active ingredient or other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is necessary when used with insulin or sulfonylureas, which can cause hypoglycemia, as the risk of hypoglycemia may increase. Experience is limited in patients with heart failure, so it should be administered cautiously. Acute pancreatitis symptoms may occur during treatment, so if there is persistent severe abdominal pain, you should stop taking the medication immediately and consult a doctor. A skin condition known as bullous pemphigoid may occur, so if blisters or sores develop on the skin, you should inform your doctor immediately and discontinue the medication if necessary. Hypoglycemic symptoms may occur during treatment, so you should respond immediately if symptoms develop. It is not recommended for pregnant women, and caution should be exercised in nursing mothers. It is advisable not to use this medication in children under 10 years of age as safety and efficacy have not been established. Elderly patients or those with impaired kidney and liver function can use it without special dosage adjustment, but their condition should be closely monitored. In the case of overdose, unabsorbed medication should be removed from the gastrointestinal tract, symptoms should be monitored, and appropriate treatment should be administered. Store the medication out of reach of children and do not transfer it to another container.

Side effects

Hypoglycemia, pancreatitis, bullous pemphigoid, nasopharyngitis, hypersensitivity, angioedema, urticaria, cough, constipation, oral ulcer formation, rash, severe and debilitating arthralgia, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, upper abdominal pain, enterocolitis, bowel obstruction, gastroenteritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disturbance, Alzheimer’s dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, gastric cancer, rectal cancer, pancreatic cancer, meniscus injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, viral upper respiratory infection, upper respiratory infection, gastroenteritis, vertigo, sensory loss, chest discomfort, weakness, pain, nosebleed, oropharyngeal pain, voice disorder, allergic rhinitis, exercise-induced dyspnea, wet cough, runny nose, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased triglycerides in blood, increased urine albumin/creatinine ratio, positive urinary leukocytes, decreased hemoglobin, increased potassium in blood, increased creatinine in blood, increased creatine phosphokinase in blood, increased ALT, increased AST, androgenetic alopecia, hyperhidrosis, hair loss, dermatitis, anxiety, affective disorder, insomnia, depression, contusion, bone contusion, concussion, fracture, hand fracture, laceration, palpitations, dry eyes, glaucoma, cataracts, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, goiter, hypertension, benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Round film-coated tablet in pink color

Package unit

28 tablets (14 tablets/PTP x 2), 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.